Rivian Automotive Option Alert: Sep 19 $16 Calls at the Bid: 5000 vs 10168 OI; Earnings 2/20 After Close 

Rivian Automotive Option Alert: Sep 19 $16 Calls at the Bid: 5000 @ $2.54 vs 10168 OI; Earnings 2/20 After Close Ref=$14.315

Rivian Automotive 株価情報 (NASDAQ: RIVN)

Rivian Automotive (NASDAQ:RIVN) 株価情報

Rivian Automotive

Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues primarily from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.

Equities

News

Markets

ABNB

DELL

RDDT

RIVN

TSLA

米株は29日に急騰し、ダウ平均株価は約300ポイント上昇し、38,997.66ドルで取引を終了した。NASDAQ総合指数とS&amp;P500はそれぞれ、1.03％上昇し、16,366.85ドル、1.04％上昇し、5,240.03ドルで取引を終了した。

米国株式市場　1日を通して投資家に注目された小型株

Large Cap

Movers

ALNY

CVNA

FTAI

MSTR

過去1週間でこれらの10本の大型株は最も良いパフォーマンスを発揮しました。投資ポートフォリオには含まれていますか？Rivian Automotive, Inc. (NASDAQ:RIVN)の株は、同社が生産を単純化し、コストを削減し、フォルクスワーゲンとの 合弁事業を発表したという報告書に続き、先週30.04％急騰しました。

過去1週間の大型株を特集　米国市場での存在感は

LCID

米国株は反発し、結果はまちまちにダウ平均は0.8％近く下落し、39,112.16ドルでした。一方、S&amp;P 500は0.4％以上上昇し、5,469.30ドルでレギュラーセッションを終えました。ナスダック指数はほぼ1.3％上昇し、17,717.65ドルで取引を終了しました。これらは、小売トレーダーや投資家の関心を集めたトップ銘柄です。

マイクロンが相場を牽引か　本日注目すべき株式

Rivian Automotive, Inc. - Class A Common Stock

Rivian Automotive Inc

Thryv Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRY#NASDAQ">THRY</a>) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.14) by 57.14 percent. This is a 200 percent decrease over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $181.37 million which beat the analyst consensus estimate of $173.83 million by 4.34 percent. This is a 22.37 percent decrease over sales of $233.62 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

THRY

Thryv Holdings Q1 EPS $(0.22) Misses $(0.14) Estimate, Sales $181.37M Beat $173.83M Estimate

Crane NXT Acquires De La Rue Authentication, Strengthening Security And Brand Protection Offerings

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4416565-1&amp;h=2075928499&amp;u=https%3A%2F%2Fidentiv.com%2F&amp;a=Identiv%2C+Inc">Identiv, Inc</a><a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4416565-1&amp;h=1142894345&amp;u=https%3A%2F%2Fidentiv.com%2F&amp;a=.">.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>), a global leader in RFID- and BLE-enabled Internet of Things (IoT) solutions, and InPlay, a wireless System-on-Chip (SoC) solution provider, today announced the co-development of a new portfolio of BLE-enabled smart labels designed for high-value logistics applications.
This collaboration marks a shared commitment to delivering innovative, scalable solutions for high-value, specialized use cases, spanning cold-chain compliance, pharmaceutical and food logistics, and asset tracking. Currently in development, the BLE smart label portfolio is expected to be commercially available in late 2025.

INVE

Identiv and InPlay Team Up to Develop BLE-Enabled Smart Labels for High-Value Logistics, To Launch Smart Labels for Cold-Chain and Asset Tracking by Late 2025

RNTX

Rein Therapeutics, Qureight Partner To Integrate AI Imaging In Phase 2 Trial Of IPF Drug LTI-03

Needham analyst John Todaro maintains Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Buy and lowers the price target from $62 to $58.

Price Target

Analyst Ratings

HOOD

Needham Maintains Buy on Robinhood Markets, Lowers Price Target to $58

Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) lowers FY2025 Adj EPS guidance from $4.00-$4.12 to $3.80-$4.00 vs $4.02 analyst estimate..

Guidance

Fortive Lowers FY2025 Adj EPS Guidance from $4.00-$4.12 to $3.80-$4.00 vs $4.02 Est

Sotera Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHC#NASDAQ">SHC</a>) affirms FY2025 Adj EPS guidance from $0.70-$0.76 to $0.70-$0.76 vs $0.74 analyst estimate. Affirms FY2025 sales outlook from $1.14 billion-$1.17 billion to $1.14 billion-$1.17 billion vs $1.13 billion estimate.

Sotera Health Affirms FY2025 Adj EPS Guidance of $0.70-$0.76 vs $0.74 Est; Affirms FY2025 Sales Guidance of $1.14B-$1.17B vs $1.13B Est

PHAT

UPDATE: Phathom Pharmaceuticals Q1 Adj. EPS $(1.07) Beats $(1.15) Estimate,

BPTH

Bio-Path Holdings Says It Has Secured Third Pre-Clinical Milestone Confirming Potential Of BP1001-A As Treatment For Obesity In Type 2 Diabetes Patients

Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) is looking for Q2 Adj EPS of $0.85-$0.90 vs $0.98 analyst estimate..

Fortive Sees Q2 Adj EPS $0.85-$0.90 vs $0.98 Est

DTIL

Precision BioSciences Announced That Five Abstracts Detailing Precision's Wholly Owned Or Partnered Programs Have Been Accepted For Presentation At The American Society Of Gene And Cell Therapy  Annual Meeting Being Held May 13-17, 2025, In New Orleans, Louisiana

Scinai Immunotherapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>), a biopharmaceutical company specializing in inflammation and immunology (I&amp;I) biological products and which provides CDMO services through its Scinai Bioservices unit, today announced that it will be hosting a webinar on Wednesday May 7th at, at 11:30 AM EST / 18:30 Israel time. The webinar will address the unmet needs in treating Pemphigus Vulgaris and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) and explore Pincell's PC111, a novel monoclonal antibody targeting soluble Fas ligand (sFasL) as a promising solution.

SCNI

Scinai to Discuss Monoclonal Antibody PC111 for Rare Skin Diseases in Upcoming Webinar

Sotera Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHC#NASDAQ">SHC</a>) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.12 by 16.67 percent. This is a 7.69 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $254.52 million which beat the analyst consensus estimate of $245.79 million by 3.55 percent. This is a 2.56 percent increase over sales of $248.18 million the same period last year.

Sotera Health Q1 Adj. EPS $0.14 Beats $0.12 Estimate, Sales $254.52M Beat $245.79M Estimate

GM CEO Barra Says Co. Assumes Pricing Will Remain What It Is Today

Needham analyst David Saxon maintains Glaukos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GKOS#NYSE">GKOS</a>) with a Buy and lowers the price target from $176 to $115.

GKOS

Needham Maintains Buy on Glaukos, Lowers Price Target to $115

Shake Shack (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) widens FY2025 sales outlook from $1.45 billion-$1.48 billion to $1.40 billion-$1.50 billion vs $1.46 billion estimate.

SHAK

Shake Shack Widens FY2025 Sales Guidance from $1.45B-$1.48B to $1.40B-$1.50B vs $1.46B Est

WIIM

CNH Industrials shares are trading lower after the company reported Q1 financial results and cut its FY25 adjusted EPS guidance with its midpoint below estimates.

Shake Shack (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) sees Q2 sales of $346.000 million-$353.000 million vs $356.38 million analyst estimate.

Shake Shack Sees Q2 Sales $346.000M-$353.000M vs $356.38M Est

Needham analyst Charles Shi reiterates KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) with a Buy and maintains $830 price target.

Reiteration

KLAC

Needham Reiterates Buy on KLA, Maintains $830 Price Target

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) narrows FY2025 Adj EPS guidance from $26.40-$27.00 to $26.60-$26.80 vs $26.73 analyst estimate..

Parker Hannifin Narrows FY2025 Adj EPS Guidance from $26.40-$27.00 to $26.60-$26.80 vs $26.73 Est

Press Releases

Rivian Certified Collision Network Grants Approval for the Autel IA900 ADAS Calibration System

Rivian Releases Fourth Quarter and Full Year 2024 Financial Results

Rivian Makes Ben & Jerry's Ice Cream Dreams Come True

Sreela Venkataratnam Joins Rivian as Chief Accounting Officer

Rivian Founder and CEO RJ Scaringe to Participate in Wolfe Research Virtual Autos Summit

Rivian Spins out Micromobility Business into New Startup—Also, Inc.

Rivian Releases Q1 2025 Production and Delivery Figures and Sets Date for First Quarter 2025 Financial Results

Rivian CFO to Participate in Bank of America Securities 2025 Automotive Summit

Aidan Gomez Joins Rivian's Board of Directors

GraniteShares 2x Long LCID Daily ETF (LCDL) and GraniteShares 2x Long RIVN Daily ETF (RVNL) Launch Today.

LCDL

RVNL

AYRO

Cenntro

Chijet Motor Company, Inc. - Ordinary Shares

Chijet Motor Co

ECD Automotive Design, Inc. - Common Stock

ECD Automotive Design

Envirotech Vehicles

Ford Motor

Faraday Future Intelligent Electric Inc. - Class A Common Stock

Faraday Future

Fly-E Group

General Motors

Honda Motor Co

Lucid Group

Li Auto Inc. - American Depositary Shares

Li Auto

Lotus Technology Inc. - American Depositary Shares

Lotus Technology

NIO Inc. American depositary shares, each representing one Class A ordinary share

NWTN

Polestar Automotive Holding UK Limited - Class A ADS

Polestar Automotive

Polestar Automotive Holding UK Limited - Class C-1 ADS (ADW)

Thor Industries

Toyota Motor

Tesla

VinFast Auto

Winnebago Industries

Workhorse Gr

XPeng Inc. American depositary shares, each representing two Class A ordinary shares

XPeng

ZEEKR Intelligent Technology Holding Limited American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

Rivian Automotive

Unusual Options Activity for

ニュース

パートナーシップ

ベンジンガ・グローバル